Compare BNR & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNR | RAND |
|---|---|---|
| Founded | 2014 | 1969 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3M | 41.2M |
| IPO Year | 2020 | N/A |
| Metric | BNR | RAND |
|---|---|---|
| Price | $21.03 | $13.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 51.5K | 2.4K |
| Earning Date | 11-20-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 12.37% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $75,749,382.00 | $7,327,287.00 |
| Revenue This Year | $136.32 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.56 | N/A |
| 52 Week Low | $2.18 | $13.25 |
| 52 Week High | $23.45 | $31.89 |
| Indicator | BNR | RAND |
|---|---|---|
| Relative Strength Index (RSI) | 73.84 | 41.82 |
| Support Level | $14.01 | $13.25 |
| Resistance Level | $23.45 | $14.00 |
| Average True Range (ATR) | 1.97 | 0.24 |
| MACD | 0.76 | 0.00 |
| Stochastic Oscillator | 80.20 | 31.66 |
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.